Center and Program Research
Center and Program Research
Explore our Faculty Publications
-
Data and Policy AnalysesDrugs on the Ballot
This page details the drug-related ballot initiatives that are up for a vote in the next election, displays gubernatorial candidate stances on marijuana, and tracks pending ballot initiatives that could impact the status of marijuana legalization. The page also provides a timeline of efforts to enact and implement marijuana reforms via the ballot box since 1996 as well as information on the results of ballot initiatives from recent years. -
Data and Policy AnalysesLocal Moratoriums for Ohio Adult Use Marijuana Operators
Like most other states that have legalized cannabis for recreational use, Ohio allows local jurisdictions to enact ordinances to prohibit or limit the operation of adult-use cannabis businesses within their boundaries, although they may not prohibit the operation of existing medical cannabis operators that are already located within their jurisdiction. This resource provides more details about the moratoriums, their purposes and intents, and what localities should consider as Ohio implements its legal cannabis market. -
Data and Policy AnalysesAdult-Use Marijuana in Ohio: What You Need to Know
On November 7, 2023, Ohio became the 24th state to legalize adult-use cannabis with 57% in favor. This page provides up-to-date information about what is and what is not allowed under the law and addresses common questions for marijuana consumers and members of the cannabis industry, and addresses tax and revenue, public safety and public health, and impact on the workplace. The information reflects the language of Senate Bill 56 which went into effect on March 20, 2026. -
Reports and StudiesMarijuana dispensaries and neighborhood crime: Evidence from a statewide natural experiment in Ohio
On August 6, 2024, sales of recreational marijuana by dispensaries began in Ohio. Treating this start of recreational sales as a natural experiment, this study executes both synthetic and canonical difference-in-differences analyses, comparing census tracts with a recreational dispensary to control census tracts with no dispensary. Findings revealed consistent decreases in total Part 1 crime and total property crime, but no substantive impacts on other crime types. There was no evidence of displacement to adjacent census tracts. We discuss the implications of these findings. -
Reports and StudiesAnother Look at the Impact of Recreational Marijuana Sales on Vehicle Crashes in Columbus, Ohio
Previous research found insufficient evidence to conclude that marijuana sales increased vehicle crashes in Columbus, Ohio. However, that analysis was limited given that it contained only 91 days post-intervention. The current study builds upon that previous research by utilizing a time series design that significantly extends the post-intervention series. -
PodcastsDrugs on the Docket S4 E5 – Criminal Justice Reform Is Not Dead with Udi Ofer
In this episode of Drugs on the Docket, Udi Ofer returns to discuss the state of criminal justice policy reform in the run up to the 2026 midterm elections. Ofer, a renowned human rights lawyer and founding director of Princeton’s Policy Advocacy Clinic, provides a compelling look at how the criminal justice reform movement has evolved. He joins hosts Hannah Miller and Douglas Berman to share insights on the role of drug policy, bipartisanship, and emerging technologies in the future of criminal justice reform. -
Data and Policy AnalysesMarijuana Reform and Taxes: How States Tax Adult Use Cannabis and Spend Resulting Revenue
This resource aims to inform discussion of marijuana taxation and revenue allocation, at both the state and local level. We detail how the Ohio initiative’s tax and revenue structures compare to the other states, provide an interactive map illustrating Host Community Cannabis Fund tax revenue per municipality, and provide the first systematic exploration into how local governments spend or are planning to spend marijuana tax revenue in states that allocate part of their overall marijuana state tax revenue to local governments. -
PodcastsDrugs on the Docket S4 E4 – Tale of Two Schedules with Sam Kamin, Robert Mikos, Cat Packer and Kathryn Cornelius
In June 2026, the Drug Enforcement and Policy Center brought together leading scholars, advocates and regulators for a webinar to explore the implications of marijuana rescheduling at the federal level, as well as what it does—and does not—change in the federal and state cannabis landscape. This conversation took place after the Trump Administration made a surprise announcement in April 2026 that it was rescheduling state medical marijuana products, but before a hearing in late June to consider full rescheduling of all forms of marijuana from Schedule I to Schedule III. This episode is a recording of that webinar and features Sam Kamin, Robert Mikos, Cat Packer and Kathryn Cornelius, in conversation with Doug Berman. Together, they explore what partial rescheduling of marijuana means in practice, and what the future could hold for adult-use marijuana. -
Data and Policy AnalysesRegulation of Intoxicating Hemp in Ohio and Beyond
This resource aims to help visitors better understand intoxicating hemp products and their regulation across the nation as well as Ohio. We present a timeline highlighting key moments in the regulation of hemp and intoxicating hemp products in Ohio and at the federal level, provide a comparison of state reform approaches and priority areas of concern with regard to these products, and assemble the center’s research on hemp regulation. -
Data and Policy AnalysesEvaluating the Ohio Medical Marijuana Control Program: Satisfaction and Perception
Our series of annual reports trace the progress of the Ohio Medical Marijuana Control Program (OMMCP). In addition to presenting survey results focused on patients’ and other users’ satisfaction levels with the program, this resource provides state data about the medical and recreational cannabis industry, and recommendations for regulators and policymakers to enhance Ohio's cannabis market for patients. -
Data and Policy AnalysesRegulating Kratom in Ohio and Beyond
In August 2025, Ohio Governor Mike DeWine called on the Ohio Board of Pharmacy (OBP) to designate all natural and synthetic kratom compounds as Schedule I drugs. This statement came just weeks after the U.S. Food and Drug Administration (FDA) announced their recommendation to place kratom compound 7-hydroxymitragynine (also referred to as 7-OH) products under Schedule I of the Controlled Substances Act (CSA). This page answers common questions about kratom and its compounds, details the regulatory efforts in Ohio and other states, and provides information on federal scheduling and public health information. -
Data and Policy AnalysesFederal Marijuana Rescheduling: Process and Impact
To better illuminate the rescheduling process, DEPC has produced a timeline highlighting key moments in the recent effort to reschedule marijuana at the federal level, provided answers to likely questions regarding the process and impact of rescheduling, gathered key documents relevant to the rescheduling process thus far, and assembled the center’s papers and webinars on the interactions between federal reforms and state marijuana laws and businesses.